Trump Allies Intervene After Scott Adams' Public Appeal for Cancer Treatment

Washington D.C. – Cartoonist Scott Adams, creator of the "Dilbert" comic strip, recently revealed that an urgent appeal for help with his metastatic prostate cancer treatment led to swift intervention from prominent figures including Donald Trump Jr., Robert F. Kennedy Jr., Dr. Mehmet Oz, and former President Donald Trump. Adams credits their involvement with potentially saving his life, stating, "there’s a very good chance" it saved his life.

Adams publicly appealed on social media platform X, detailing difficulties in scheduling a crucial Pluvicto treatment with his healthcare provider, Kaiser Permanente of Northern California. He specifically asked former President Trump for assistance, writing, "I am declining fast. I will ask President Trump if he can get Kaiser of Northern California to respond and schedule it for Monday."

The cartoonist recounted the rapid response, noting that Donald Trump Jr. contacted him from Africa, assuring him, "I'm on this. My father wants me to get this done." Robert F. Kennedy Jr. also reached out, asking, "What can I do? What's the situation?" followed by a call from Dr. Mehmet Oz. Former President Trump himself posted Adams' message on X, adding a concise "On it!"

Adams, a vocal supporter of former President Trump, had previously revealed his diagnosis of metastatic prostate cancer, which had spread to his bones. He stated that Kaiser Permanente had approved his application for the FDA-approved drug Pluvicto but had "dropped the ball" on scheduling the intravenous administration. Pluvicto is a targeted radioligand therapy used for advanced prostate cancer.

Following the high-profile interventions, Adams observed a significant shift at his healthcare provider. He noted, "It turns out that nobody in senior management at Kaiser, my health care company, had a good weekend." Kaiser Permanente issued a statement confirming that Adams' oncology team was "working closely with him on the next steps in his cancer care, which are already underway," adding they had treated over 150 patients with Pluvicto in Northern California since its approval.

The incident has sparked public discussion regarding preferential treatment in the healthcare system. While many expressed well-wishes for Adams, others on social media questioned why such high-level intervention was necessary for one individual, highlighting broader issues within the U.S. healthcare system.